Table 4.
Antidepressant use by aMCI status (n = 67)
| Variable | aMCI − (n = 49) | aMCI + (n = 18) | p value | Effect size |
|---|---|---|---|---|
| On antidepressant, n (%) | 15 (30.6%) | 11 (61.1%) | .02 | OR = 3.56 (1.16, 10.98) |
| On atypical, n (%) | 9 (18.4%) | 5 (27.8%) | .50a | OR = 1.71 (0.49, 6.02) |
| On bupropion HCL, n (%) | 4 (8.2%) | 3 (16.7%) | .38a | OR = 2.25 (0.45, 11.22) |
| On trazodone HCL, n (%) | 4 (8.2%) | 3 (16.7%) | .38a | OR = 2.25 (0.45, 11.22) |
| On mirtazapine, n (%) | 2 (4.1%) | 2 (11.1%) | .29a | OR = 2.94 (0.38, 22.60) |
| On SSRI, n (%) | 5 (10.2%) | 6 (33.3%) | .06a | OR = 4.40 (1.14, 16.93) |
| On escitalopram oxalate, n (%) | 3 (6.1%) | 1 (5.6%) | 1.00a | OR = 0.90 (0.09, 9.28) |
| On fluoxetine, n (%) | 2 (4.1%) | 1 (5.6%) | 1.00a | OR = 1.38 (0.12, 16.24) |
| On sertraline HCL, n (%) | 0 (0.0%) | 2 (11.1%) | .07a | |
| On paroxetine, n (%) | 0 (0.0%) | 1 (5.6%) | .27a | |
| On citalopram HBR, n (%) | 0 (0.0%) | 1 (5.6%) | .27a | |
| On SNRI, n (%) | 4 (8.2%) | 1 (5.6%) | 1.00a | OR = 0.66 (0.07, 6.35) |
| On venlafaxine HCL, n (%) | 3 (6.1%) | 1 (5.6%) | 1.00a | OR = 0.90 (0.09, 9.28) |
| On duloxetine HCL, n (%) | 1 (2.0%) | 0 (0.0%) | 1.00a | |
| On tricyclics, n (%) | 3 (6.1%) | 1 (5.6%) | 1.00a | OR = 0.90 (0.09, 9.28) |
| On amitriptyline HCL, n (%) | 2 (4.1%) | 1 (5.6%) | 1.00a | OR = 1.38 (0.12, 16.24) |
| On desipramine, n (%) | 1 (2.0%) | 0 (0.0%) | 1.00a |
ap value corresponds to Fisher’s exact test